Lars Henning Engelholm

Lars Henning Engelholm

ORCID: 0000-0002-6616-1232

Publication year:
All
1 - 3 out of 3Page size: 10
Sort by: 1st author
  1. Published

    The Urokinase Receptor (uPAR) as a “Trojan Horse” in Targeted Cancer Therapy: Challenges and Opportunities

    Metrangolo, Virginia, Ploug, Michael & Engelholm, Lars Henning, 2021, In: Cancers. 13, 21, 45 p., 5376.

    Research output: Contribution to journal › Review › Research › peer-review

  2. Published

    Osteosarcoma and metastasis associated bone degradation—a tale of osteoclast and malignant cell cooperativity

    Nørregaard, Kirstine Sandal, Jürgensen, Henrik Jessen, Gårdsvoll, Henrik, Engelholm, Lars Henning, Behrendt, Niels & Søe, K., 2021, In: International Journal of Molecular Sciences. 22, 13, 6865.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    The Collagen Receptor uPARAP in Malignant Mesothelioma: A Potential Diagnostic Marker and Therapeutic Target

    Cakilkaya, Pinar, Sørensen, R. R., Jürgensen, Henrik Jessen, Krigslund, O., Gårdsvoll, Henrik, Nielsen, C. F., Santoni Rugiu, Eric, Behrendt, Niels & Engelholm, Lars Henning, 2021, In: International Journal of Molecular Sciences. 22, 21, 17 p., 11452.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 9647887